Bridging the European Pharmacopoeia (Ph. Eur.) and BfArM regulatory expectations with premier, data-driven contract analytical research. Validated HPTLC, HPLC-MS/MS, and high-precision fingerprint profiling delivering scientific transparency from raw botanicals to clinical grade actives.
Core ODM bioanalytical method workflows engineered to meet German regulatory precision, natural medicine dossiers, and European research standards.
Why analytical method development has become the strategic bottleneck for health innovators in Germany’s capital region.
Berlin serves as a nucleus for pharmaceutical trade and regulatory consultancy in Germany. Under the guidance of the Federal Institute for Drugs and Medical Devices (BfArM) and the European Medicines Agency (EMA) botanical guidance, traditional herbal medicinal products (THMPD) and innovative nutraceuticals face extraordinary documentation demands.
Establishing unambiguous qualitative fingerprints and quantitative assays is mandatory to overcome strict registration thresholds.
From the biotech spin-offs emerging from Berlin-Buch to deep-tech health incubators in Adlershof, the regional market thrives on rapid proof-of-concept transitions. Startups frequently develop novel active compound delivery systems but lack the localized infrastructure for custom HPLC-MS method creation.
External contract research fills critical equipment deficits, accelerating time-to-clinic.
German consumer skepticism requires total clarity regarding pesticide residues, heavy metals, synthetic adulterants, and batch uniformity. In response, German brand curators are moving beyond simple certificates of analysis (CoA) toward comprehensive chemical fingerprinting.
Method development ensures raw material batches maintain identity fidelity across global supply channels.
Delivering high-dimensional analytics, deep herbal reference libraries, and smooth transition from analytical development to high-volume commercial production.
Centuries of classical botanical science combined with over 14 years of modern experimental CRO records allow Chinese facilities to compare samples against an expansive library of plant fractions, authentic standards, and specialized markers that are costly to procure in Western Europe.
Operating hundreds of chromatography lines (UPLC, HPLC-MS/MS, GC-FID, Prep-HPLC, and HPTLC) ensures methods are not only validated under controlled bench settings but are stress-tested against commercial production parameters, pilot extraction cycles, and high-throughput QA/QC routines.
Our operational model runs on locked research pipelines. Client-owned active compound structures, separation parameters, elution gradients, and yield enrichment recipes are strictly protected by contractual non-disclosure agreements and segmented digital storage.
Modern botanical drug discovery has moved from single-compound quantification to dynamic multi-component metabolomics.
Modern European consumers and scientific reviewers demand proof that natural remedies maintain an unaltered chemical balance. Utilizing High-Performance Thin-Layer Chromatography (HPTLC) and Ultra-Performance Liquid Chromatography (UPLC), we establish comprehensive fingerprint maps that guarantee the profile of active ingredients remains constant, preventing raw herb falsification.
Global pharmaceutical supply lines require absolute verification of specificity, linearity, precision (repeatability and intermediate precision), limit of detection (LOD), limit of quantitation (LOQ), and robustness. Our methodology is natively compiled to suit ICH guidelines, making data portfolios immediately usable for European regulatory submission dossiers.
Complex natural extracts frequently suffer from matrix interference, where sugars, tannins, and non-target lipids mask critical active peaks. We design customized solid-phase extraction (SPE) and selective liquid-liquid clean-up methods that isolate active fractions, ensuring reproducible baseline separation even in low-potency formulations.
Actionable ODM analytical methodologies tailored for dynamic German life-science business models.
Health startups centered around Berlin-Mitte and Kreuzberg require novel, clean-label antioxidant and adaptogenic extracts (e.g., adaptogenic mushroom triterpenes, specialized polyphenols). We build rigorous stability-indicating HPLC testing regimens that verify compound viability over a 24-month shelf life under European climatic zones (Zone I/II).
Biomedical ventures conducting human studies in partnership with academic hospitals require sensitive, selective bio-analytical methods to measure trace active metabolites in serum and urine samples. Our ODM analytical pipeline establishes GLP-aligned quantification protocols for pharmacokinetics (PK) and pharmacodynamics (PD).
Established German wellness enterprises seeking to substantiate distinctive marketing claims can deploy our targeted analytical methodology to demonstrate batch consistency, verified active ingredient thresholds, and the total absence of harmful degradation products or heavy metal traces.
Technical insight addressing the operational, regulatory, and quality concerns of European procurement professionals.
Complete contract discovery, in vitro verification, method validation, and clinical research capabilities supporting the entire life cycle of botanical innovation.
